Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis.

Gao J. et al, (2022), J Neurol

Genetic testing in motor neurone disease

Dharmadasa T. et al, (2022), Practical Neurology, 22, 107 - 116

Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain

Thompson AG. et al, (2022), Brain Communications, 4

Advancing Mechanistic Understanding and Biomarker Development in Amyotrophic Lateral Sclerosis.

Thompson AG. et al, (2021), Expert Rev Proteomics

Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis

Thompson AG. et al, (2021), Journal of Neurology, Neurosurgery & Psychiatry

Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers

Vahsen BF. et al, (2021), Nature Reviews Neurology

A mechanic with confusion and right-sided weakness.

Edmond EC. et al, (2021), Pract Neurol

Network Analysis of the CSF Proteome Characterizes Convergent Pathways of Cellular Dysfunction in ALS.

Thompson AG. et al, (2021), Front Neurosci, 15

CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis

Thompson AG. et al, (2020), Clinical Proteomics, 17

An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress

Feneberg E. et al, (2020), Neurobiology of Disease, 144, 105050 - 105050

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis

Gray E. et al, (2020), Annals of Clinical and Translational Neurology

Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis

Joilin G. et al, (2020), Brain Communications, 2

A TRIAGING BLOOD TEST FOR NEUROLOGY? SERUM NEUROFILAMENT LEVELS IN A COHORT OF GP REFERRALS

Robertson J. et al, (2019), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, E22 - E23

CSF chitinase proteins in amyotrophic lateral sclerosis

Thompson AG. et al, (2019), Journal of Neurology, Neurosurgery & Psychiatry, 90, 1215 - 1220

Untangling neuroinflammation in amyotrophic lateral sclerosis

Thompson AG. and Turner MR., (2019), Journal of Neurology, Neurosurgery & Psychiatry

The interactome of human TDP-43 in a cellular model of amyotrophic lateral sclerosis

Feneberg E. et al, (2019), EUROPEAN JOURNAL OF NEUROLOGY, 26, 221 - 222

UFLC‐Derived CSF Extracellular Vesicle Origin and Proteome

Thompson AG. et al, (2018), PROTEOMICS, 1800257 - 1800257

Amyotrophic lateral sclerosis: the complex path to precision medicine

Talbot K. et al, (2018), Journal of Neurology, 265, 2454 - 2462

Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis

Salter M. et al, (2018), EBioMedicine, 33, 169 - 184

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Lewczuk P. et al, (2018), The World Journal of Biological Psychiatry, 19, 244 - 328

Load More

Include forthcoming?